UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Hormonal modulation of ESR1 mutant metastasis

Oncogene, 2021-02, Vol.40 (5), p.997-1011

2021

Volltextzugriff (PDF)

Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight

Breast cancer research and treatment, 2014-02, Vol.144 (1), p.11-19

2014

Volltextzugriff (PDF)

The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer

Hormones & cancer, 2018-08, Vol.9 (4), p.215

2018

Volltextzugriff (PDF)

AR collaborates with ERα in aromatase inhibitor-resistant breast cancer

Breast cancer research and treatment, 2014-10, Vol.147 (3), p.473-485

2014

Volltextzugriff (PDF)

Abstract PD1-07: Mutant ESR1 receptors antagonize the tumor suppressor function of androgen receptors

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD1-07-PD1-07

2022

Volltextzugriff (PDF)

ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

Breast cancer research and treatment, 2016-06, Vol.157 (2), p.253-265

2016

Volltextzugriff (PDF)

Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer

Breast cancer research and treatment, 2015-11, Vol.154 (2), p.225-237

2015

Volltextzugriff (PDF)

Abstract PD8-09: Androgen and ESR1 mutant receptors mechanistically collaborate for overexpression of genes associated with poor outcomes in ER-positive metastatic breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD8-09-PD8-09

2021

Volltextzugriff (PDF)

Abstract 22: The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.22-22

2018

Volltextzugriff (PDF)

Abstract PD6-6: Estrogen receptor (ESR1) mutations confer resistance to hormone therapy using a common mechanism

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.PD6-6-PD6-6

2015

Volltextzugriff (PDF)

Correction to: Hormonal modulation of ESR1 mutant metastasis

Oncogene, 2022-01, Vol.41 (3), p.460-460

2022

Volltextzugriff (PDF)

Targeting thyroid hormone receptor beta in triple-negative breast cancer

Breast cancer research and treatment, 2015-04, Vol.150 (3), p.535-545

2015

Volltextzugriff (PDF)

The role of androgen receptor in breast cancer

Drug discovery today. Disease mechanisms, 2012-01, Vol.9 (1-2), p.e19-e27

2012

Volltextzugriff (PDF)

Erratum to: ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

Breast cancer research and treatment, 2017-06, Vol.163 (3), p.639-640

2017

Volltextzugriff (PDF)

Collaboration of AR and ERα in conferring resistance to an aromatase inhibitor

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.579-579

2013

Volltextzugriff (PDF)

Estrogen receptor (ER) [alpha] mutations in breast cancer: hidden in plain sight

Breast cancer research and treatment, 2014-02, Vol.144 (1), p.11-19

2014

Volltextzugriff (PDF)

New insights into HCV replication in original cells from Aedes mosquitoes

Virology journal, 2017-08, Vol.14 (1), p.161-161, Article 161

2017

Volltextzugriff (PDF)

Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ER[alpha]-positive breast cancer

Breast cancer research and treatment, 2015-11, Vol.154 (2), p.225

2015

Volltextzugriff (PDF)

Abstract 1083: Nuclear receptors as novel targets in ER negative breast cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1083-1083

2012

Volltextzugriff (PDF)

Micro-RNAs: viral genome and robustness of gene expression in the host

Philosophical transactions of the Royal Society of London. Series A: Mathematical, physical, and engineering sciences, 2009-12, Vol.367 (1908), p.4941-4965

2009

Volltextzugriff (PDF)

An innovative role of thyroid receptor β in triple‐negative breast cancer (58.4)

The FASEB journal, 2014-04, Vol.28 (S1), p.n/a

2014

Volltextzugriff (PDF)

AR collaborates with ER[alpha] in aromatase inhibitor-resistant breast cancer

Breast cancer research and treatment, 2014-10, Vol.147 (3), p.473

2014

Volltextzugriff (PDF)

ESR1 Mutations in Cell-Free DNA of Breast Cancer: Predictive "Tip of the Iceberg"

JAMA oncology, 2016-10, Vol.2 (10), p.1315

2016

Volltextzugriff (PDF)

Abstract 940: AR overexpression confers resistance to an aromatase inhibitor in ERα-positive breast cancer cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.940-940

2011

Volltextzugriff (PDF)

Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody

Journal of medical virology, 2009-10, Vol.81 (10), p.1726-1733

2009

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hormonal modulation of ESR1 mutant metastasis

Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight

The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer

AR collaborates with ERα in aromatase inhibitor-resistant breast cancer

Abstract PD1-07: Mutant ESR1 receptors antagonize the tumor suppressor function of androgen receptors

ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer

Abstract PD8-09: Androgen and ESR1 mutant receptors mechanistically collaborate for overexpression of genes associated with poor outcomes in ER-positive metastatic breast cancer

Abstract 22: The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis

Abstract PD6-6: Estrogen receptor (ESR1) mutations confer resistance to hormone therapy using a common mechanism

Correction to: Hormonal modulation of ESR1 mutant metastasis

Targeting thyroid hormone receptor beta in triple-negative breast cancer

The role of androgen receptor in breast cancer

Erratum to: ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

Collaboration of AR and ERα in conferring resistance to an aromatase inhibitor

Estrogen receptor (ER) [alpha] mutations in breast cancer: hidden in plain sight

New insights into HCV replication in original cells from Aedes mosquitoes

Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ER[alpha]-positive breast cancer

Abstract 1083: Nuclear receptors as novel targets in ER negative breast cancer

Micro-RNAs: viral genome and robustness of gene expression in the host

An innovative role of thyroid receptor β in triple‐negative breast cancer (58.4)

AR collaborates with ER[alpha] in aromatase inhibitor-resistant breast cancer

ESR1 Mutations in Cell-Free DNA of Breast Cancer: Predictive "Tip of the Iceberg"

Abstract 940: AR overexpression confers resistance to an aromatase inhibitor in ERα-positive breast cancer cells

Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody

Suchergebnisse filtern